Spatial control of gene expression within a scaffold by localized inducer release.
Gene expression can be controlled in genetically modified cells by employing an inducer/promoter system where presence of the inducer molecule regulates the timing and level of gene expression. By applying the principles of controlled release, it should be possible to control gene expression on a biomaterial surface by the presence or absence of inducer release from the underlying material matrix, thus avoiding alternative techniques that rely upon uptake of relatively labile DNA from material surfaces. To evaluate this concept, a modified ecdysone-responsive gene expression system was transfected into B16 murine cells and the ability of an inducer ligand, which was released from elastomeric poly(ester urethane) urea (PEUU), to initiate gene expression was studied. The synthetic inducer ligand was first loaded into PEUU to demonstrate extended release of the bioactive molecule at various loading densities over a one year period in vitro. Patterning films of PEUU variably-loaded with inducer resulted in spatially controlled cell expression of the gene product (green fluorescent protein, GFP). In porous scaffolds made from PEUU by salt leaching, where the central region was exclusively loaded with inducer, cells expressed GFP predominately in the loaded central regions whereas expression was minimal in outer regions where ligand was omitted. This scaffold system may ultimately provide a means to precisely control progenitor cell commitment in a spatially-defined manner in vivo for soft tissue repair and regeneration.
Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Priya R
PR
Baraniak
Devin M
DM
Nelson
Cory E
CE
Leeson
Anand K
AK
Katakam
Jennifer L
JL
Friz
Dean E
DE
Cress
Yi
Y
Hong
Jianjun
J
Guan
William R
WR
Wagner
D000818:Animals; D001672:Biocompatible Materials / Q000494:pharmacology*; D045744:Cell Line, Tumor; D015870:Gene Expression / Q000187:drug effects*; D051379:Mice; D023822:Tissue Engineering
D001672:Biocompatible Materials
J Biomed Mater Res A. 2009 Sep 15;90(4):1054-65
18671269
Curr Gene Ther. 2006 Aug;6(4):421-38
16918333
J Cell Biol. 2005 Dec 5;171(5):883-92
16314431
Cardiovasc Res. 2007 Jul 1;75(1):178-85
17481597
J Neurosci. 2006 Aug 23;26(34):8866-74
16928876
Biomaterials. 2006 Feb;27(5):735-44
16095685
Trends Endocrinol Metab. 2007 Sep;18(7):261-5
17693094
J Biomed Mater Res. 2002 Sep 5;61(3):493-503
12115475
Math Biosci. 2007 Sep;209(1):30-50
17363011
Cell Biochem Biophys. 2008;52(2):85-102
18841496
Eur J Biochem. 2003 Mar;270(6):1308-15
12631289
Adv Drug Deliv Rev. 2006 Jul 7;58(4):500-14
16759734
FASEB J. 2008 Jun;22(6):2084-9
18203957
Cell. 2002 Aug 9;110(3):385-97
12176325
Biomaterials. 2005 Apr;26(10):1139-44
15451633
Biomaterials. 2005 Nov;26(33):6762-70
15941581
J Biomed Mater Res A. 2003 Sep 1;66(3):586-95
12918042
Biomaterials. 2010 Apr;31(12):3253-65
20138661
J Control Release. 2004 Jun 18;97(2):249-57
15196752
Cell. 2006 Aug 25;126(4):663-76
16904174
Tissue Eng Part A. 2010 Apr;16(4):1215-23
19895206
Biotechnol Prog. 2001 Sep-Oct;17(5):935-44
11587587
Expert Rev Med Devices. 2004 Sep;1(1):127-38
16293016
Biomaterials. 2007 Jun;28(16):2603-11
17324456
Biomaterials. 2003 Dec;24(28):5163-71
14568433
Microsc Res Tech. 2005 Apr 15;66(6):275-88
16003781
Cancer Res. 2009 Aug 1;69(15):6184-91
19643734
J Pharm Sci. 2004 Jan;93(1):132-43
14648643
J Cell Biol. 2000 Dec 11;151(6):1269-80
11121441
Acta Biomater. 2010 Aug;6(8):2889-97
20167291
Mol Ther. 2005 Aug;12(2):189-211
15946903
Prostate. 2007 Jun 1;67(8):808-19
17373718
Cell. 2010 Aug 6;142(3):375-86
20691899
Biomaterials. 2006 Apr;27(10):2213-21
16325254
Nature. 2009 Jun 4;459(7247):708-11
19396158
Biomacromolecules. 2009 Oct 12;10(10):2729-39
19754121
J Control Release. 2007 Jul 16;120(1-2):70-8
17509717
Arch Immunol Ther Exp (Warsz). 2007 May-Jun;55(3):139-49
17557142
Ann Thorac Surg. 2007 Feb;83(2):648-54
17258002
Expert Opin Drug Deliv. 2008 Feb;5(2):175-87
18248317
J Biomed Mater Res. 2002 Jun 5;60(3):472-9
11920672
Anal Chim Acta. 2008 Feb 18;609(1):59-65
18243874
Exp Neurol. 2008 Jan;209(1):30-3
17942096
Biotechniques. 2005 Aug;39(2):191-2, 194, 196 passim
16116792
Biomaterials. 2007 Apr;28(12):2069-76
17254631
Expert Opin Biol Ther. 2007 Aug;7(8):1123-7
17696812
Mol Ther. 2009 Feb;17(2):318-26
19050701
J Biomed Mater Res A. 2008 May;85(2):530-8
17729252
J Biomed Mater Res A. 2006 Oct;79(1):176-84
16788907
Nature. 2008 Oct 2;455(7213):627-32
18754011
J Control Release. 1999 Aug 5;60(2-3):149-60
10425321
Gene Ther. 2000 Jan;7(2):120-5
10673717
Trends Genet. 2003 Dec;19(12):701-8
14642751
J Biol Chem. 2004 Jun 25;279(26):27211-8
15107428
J Am Coll Cardiol. 2007 Jun 12;49(23):2292-300
17560295
Stem Cells. 2008 Jan;26(1):127-34
17901398
Langmuir. 2007 Nov 20;23(24):12261-8
17949112
J Cell Biochem. 2002;87(3):342-59
12397616